合成路线1
该中间体在本合成路线中的序号:
(I) The synthesis of [14C]-labeled 15-deoxyspergualin trihydrochloride has been reported:
The condensation of [14C]-labeled S-methylisothiourea (I) with 7-aminoheptanoic acid (II) by means of NaOH in water gives 7-guanidinoheptanoic acid (III), which is treated with Dowex 50W resin (H+ form) in refluxing methanol yielding the corresponding methyl ester (IV). The reaction of (IV) with concentrated NH4OH affords the amide (V), which is finally condensed with glyoxyloxyspermidine (VI) by means of glutaric acid in hot water (60 C), and purified by chromatography over Sephadex CM-25 (Na+ form).
【1】
Dischino, D.D.; Synthesis of carbon-14 labeled (±) 15-deoxyspergualin trihydrochloride. J Label Compd Radiopharm 1995, 36, 11, 1097.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(I) |
44636 |
[[amino(imino)methyl]sulfanyl]methane
|
|
C2H6N2S |
详情 |
详情
|
(II) |
10273 |
7-Aminoheptanoic acid
|
929-17-9 |
C7H15NO2 |
详情 | 详情
|
(III) |
10274 |
7-[[Amino(imino)methyl]amino]heptanoic acid
|
|
C8H17N3O2 |
详情 |
详情
|
(III) |
44637 |
7-[[amino(imino)methyl]amino]heptanoic acid
|
|
C8H17N3O2 |
详情 |
详情
|
(IV) |
10275 |
methyl 7-[[amino(imino)methyl]amino]heptanoate
|
|
C9H19N3O2 |
详情 |
详情
|
(IV) |
44638 |
methyl 7-[[amino(imino)methyl]amino]heptanoate
|
|
C9H19N3O2 |
详情 |
详情
|
(V) |
10270 |
7-[[Amino(imino)methyl]amino]heptanamide
|
|
C8H18N4O |
详情 |
详情
|
(V) |
44639 |
7-[[amino(imino)methyl]amino]heptanamide
|
|
C8H18N4O |
详情 |
详情
|
(VI) |
10271 |
N-[4-[(3-Aminopropyl)amino]butyl]-2,2-dihydroxyacetamide
|
|
C9H21N3O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The condensation of S-methylisothiourea (I) with trans-4-(aminomethyl)cyclohexanecarboxylic acid (II) by means of NaOH in water gives trans-4-(guanidinomethyl)cyclohexanecarboxylic acid (III) (I), which is esterified with benzyl salicylate (IV) by means of dicyclohexylcarbodiimide (DCC) or SOCl2 yielding 2-benzyloxycarbonylphenyl trans-4-(guanidinomethyl)cyclohexanecarboxylate (V). Finally, this compound is treated with cyclodextrin in aqueous solution to afford the corresponding complex.
【1】
Umeyama, M.; Ooi, Y.; Muramutu, M.; Miyataka, H.; Nakajima, T.; Satoh, T.; Medicinal chemical studies on synthetic protease i. Chem Pharm Bull 1985, 33, 2, 647.
|
【2】
Villani, F.J. (Schering Corp.); Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6. US 4282233 .
|
【3】
Prous, J.; Castaner, J.; TA-903. Drugs Fut 1987, 12, 5, 451.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(II) |
23058 |
4-(aminomethyl)cyclohexanecarboxylic acid
|
1197-18-8 |
C8H15NO2 |
详情 | 详情
|
(III) |
23059 |
4-([[amino(imino)methyl]amino]methyl)cyclohexanecarboxylic acid
|
|
C9H17N3O2 |
详情 |
详情
|
(IV) |
23060 |
benzyl salicylate
|
118-58-1 |
C14H12O3 |
详情 | 详情
|
(V) |
23061 |
benzyl 2-([[4-([[amino(imino)methyl]amino]methyl)cyclohexyl]carbonyl]oxy)benzoate
|
|
C23H27N3O4 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(V) 1) By methanolysis of 2,6-dichlorophenylacetonitrile (I) by means of H2SO4 to methyl 2,6-dichlorophenylacetate (II), which is then condensed with guanidine (A) in isopropanol.
2) By condensation of S-methylisothiourea (V) with 2,6-dichlorophenylacetyl chloride (VI) in acetone to afford S-methyl-N-(2,6-dichlorophenylacetyl)isothiourea (VII); this product is then treated with ammonia in isopropanol.
3) By condensation of 2,6-dichlorophenylacetic acid (VIII) with guanidine (A) in toluene.
【1】
Arrigoni-Martelli, E.; Castaner, J.; BS 100-141. Drugs Fut 1976, 1, 4, 167.
|
【2】
Bream, J.B.; et al.; Substituted phenylacetylguanidines: A new class of antihypertensive agents. Arzneim-Forsch Drug Res 1975, 25, 10, 1477.
|
【3】
Bream, J.B.; et al. (Novartis AG); Substituted phenylacethyl derivatives of guanidine, O-alkylisoureas, S-alkylisothioureas and p-benzylalkylisothioureas. DE 179348; FR 1584670; GB 1235723; US 3632645 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14790 |
Guanidine
|
113-00-8 |
CH5N3 |
详情 | 详情
|
(I) |
18202 |
2-(2,6-dichlorophenyl)acetonitrile; 2,6-Dichlorophenylacetonitrile
|
3215-64-3 |
C8H5Cl2N |
详情 | 详情
|
(II) |
40327 |
methyl 2-(2,6-dichlorophenyl)acetate
|
54551-83-6 |
C9H8Cl2O2 |
详情 | 详情
|
(V) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(VI) |
40329 |
2-(2,6-dichlorophenyl)acetyl chloride
|
|
C8H5Cl3O |
详情 |
详情
|
(VII) |
40330 |
1,3-dichloro-2-(2-[[imino(methylsulfanyl)methyl]amino]-2-oxoethyl)benzene
|
|
C10H10Cl2N2OS |
详情 |
详情
|
(VIII) |
40328 |
2-(2,6-dichlorophenyl)acetic acid
|
6575-24-2 |
C8H6Cl2O2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(IV) The reaction of 5-isoquinolinesulfonyl chloride (I) with ethyldiamine (II) in methylene chloride gives N-(2-aminoethyl)isoquinoline-5-sulfonamide (III), which is then condensed with S-methylisothiourea sulfate (IV) by means of NaOH at 80 C.
【1】
Asano, T.; Hidaka, H.; Vasodilatory action of HA-1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no efect on cardiac function. J Pharmacol Exp Ther 1984, 231, 1, 141.
|
【2】
Koch, H.; Castaner, J.; HA-1004. Drugs Fut 1985, 10, 10, 815.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27362 |
5-isoquinolinesulfonyl chloride
|
84468-15-5 |
C9H6ClNO2S |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
27363 |
N-(2-aminoethyl)-5-isoquinolinesulfonamide
|
|
C11H13N3O2S |
详情 |
详情
|
(IV) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(IX) The reaction of 2,3-dichlorobenzoic acid (I) with oxalyl chloride in dichloromethane gives the acyl chloride (II), which is condensed with labeled copper cyanide (III) by means of KI in refluxing xylene to yield the 2,3-dichlorobenzoyl cyanide (IV). The condensation of (IV) with labeled aminoguanidine (V) by means of sulfuric acid in acetonitrile/water affords adduct (VI), which is finally cyclized by refluxing under the conditions of the preceding reaction to provide the target labeled diaminotriazine.
The intermediate labeled copper cyanide (III) has been obtained by reaction of CuSO4 with labeled potassium cyanide (VII) and Na2S2O5 in hot water.
The intermediate labeled aminoguanidine (V) has been obtained by methylation of thiourea (VIII) with dimethyl sulfate in boiling water to give S-methylisothiourea (IX), which is finally treated with hydrazine (X) and NaOH in water.
【1】
Manning, C.O.; et al.; Synthesis of stable isotopically labelled versions of lamotrigine and its methylated metabolite. J Label Compd Radiopharm 2002, 45, 7, 611.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24007 |
2,3-dichlorobenzoic acid
|
50-45-3 |
C7H4Cl2O2 |
详情 | 详情
|
(II) |
24008 |
2,3-dichlorobenzoyl chloride
|
2905-60-4 |
C7H3Cl3O |
详情 | 详情
|
(III) |
56856 |
Copper (I) cyanide; Cuprous cyanide
|
544-92-3 |
CCuN |
详情 | 详情
|
(III) |
56861 |
cyanocopper
|
|
CCuN |
详情 |
详情
|
(IV) |
24009 |
2-(2,3-dichlorophenyl)-2-oxoacetonitrile; 2,3-Dichlorobenzoylcyanide
|
77668-42-9 |
C8H3Cl2NO |
详情 | 详情
|
(IV) |
56862 |
2-(2,3-dichlorophenyl)-2-oxoacetonitrile
|
|
C8H3Cl2NO |
详情 |
详情
|
(V) |
56857 |
|
|
CH6N4 |
详情 |
详情
|
(V) |
56866 |
|
|
CH6N4 |
详情 |
详情
|
(VI) |
56858 |
1,2-dichloro-3-{cyano[(Z)-2-(diaminomethylene)hydrazono]methyl}benzene
|
|
C9H7Cl2N5 |
详情 |
详情
|
(VI) |
56867 |
1,2-dichloro-3-{cyano[(Z)-2-(diaminomethylene)hydrazono]methyl}benzene
|
|
C9H7Cl2N5 |
详情 |
详情
|
(VII) |
56859 |
Potassium cyanide
|
151-50-8 |
CKN |
详情 | 详情
|
(VII) |
56860 |
cyanopotassium
|
|
CKN |
详情 |
详情
|
(VIII) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(VIII) |
56863 |
thiourea
|
|
CH4N2S |
详情 |
详情
|
(IX) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(IX) |
56864 |
{[amino(imino)methyl]sulfanyl}methane
|
|
C2H6N2S |
详情 |
详情
|
(X) |
27344 |
hydrazine
|
302-01-2 |
H4N2 |
详情 | 详情
|
(X) |
56865 |
hydrazine
|
|
H4N2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
This compound can be prepared by two related ways:
1) The diazotation of L-serine methyl ester (I) with NaNO2 - HCl gives methyl (S)-glycerate (II), which by reaction with 2,2-dimethoxypropane and p-toluenesulfonic acid (or acetone and ZnCl2) is converted to methyl (S)-O-isopropylideneglycerate (III). The reduction of (III) with LiAlH4 in refluxing ether affords (S)-2,3-O-isopropylideneglycerol (IV), which by reaction with tosyl chloride in pyridine is converted to the corresponding tosylate (V). The partial hydrolysis of (V) with HCl in acetone affords (S)-glycerol-1-tosylate (VI), which is finally condensed with 1-phenylpiperazine (VII) in refluxing benzene.
2) The partial hydrolysis of (S)-2,3-epoxypropyl tosylate (VIII) with HCl as before gives the glycerol tosylate (VI), already obtained.
【1】
Borsa, M.; Tonon, G.; Malandrino, S. (Dompé Farm. SpA); Optically active compounds with antitussive and central sedative activity, a process for the preparation thereof and compositions containing the same. EP 0147847; US 4699911; US 4764515 . |
【2】
Giani, R.; Marione, E.; Melillo, G.; Borsa, M.; Tonon, G.C.; Synthesis and pharmacological screening of new phenylpiperazinepropane derivatives and their enantiomers. Arzneim-Forsch Drug Res 1988, 38, 8, 1139-41.
|
【3】
Prous, J.; Castaner, J.; LEVDROPROPIZINE < Rec INN >. Drugs Fut 1989, 14, 6, 522.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
20916 |
methyl (2R)-2,3-dihydroxypropanoate
|
|
C4H8O4 |
详情 |
详情
|
(III) |
20917 |
methyl (4R)-2,2-dimethyl-1,3-dioxolane-4-carboxylate
|
52373-72-5 |
C7H12O4 |
详情 | 详情
|
(IV) |
12709 |
[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methanol
|
22323-82-6 |
C6H12O3 |
详情 | 详情
|
(V) |
20919 |
[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate
|
23788-74-1 |
C13H18O5S |
详情 | 详情
|
(VI) |
20920 |
(2R)-2,3-dihydroxypropyl 4-methylbenzenesulfonate
|
|
C10H14O5S |
详情 |
详情
|
(VII) |
10756 |
N-Phenylpiperazine; 1-Phenylpiperazine; Phenyl piperazine
|
92-54-6 |
C10H14N2 |
详情 | 详情
|
(VIII) |
16242 |
(2R)oxiranylmethyl 4-methylbenzenesulfonate; (2R)-(-)-Glycidyl tosylate
|
113826-06-5 |
C10H12O4S |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(VII) Nitroacetaldehyde oxime (I) is formed from nitromethane in the presence of NaOH and is converted in acidic media with 2-aminobenzoic acid (II) to 2-(2-nitroethylideneamino)benzoic acid (III). Cyclization of (III) in acetic anhydride by means of potassium acetate yields 4-hydroxy-3-nitroquinoline (IV), which is converted to 4-chloro-3-nitroquinoline (V) in boiling POCl3. Reaction of (V) with morpholinecarboximidamide (VIII) (formed from morpholine (VI) and S-methylisothiourea hemisulfate (VII) in ethanol) affords troquidazole.
【1】
Berényi, E.; Varga, L.; Pallos, L.; Petöcz, L.; Ladányi, L.; Tömpe, P.; Hartai, E.; Kovács, A. (Egis Pharmaceuticals Ltd.); N-(3-Nitroquinolin-4-yl)guanidine derivatives as radiosensitizers. (EGIS Pharm., Ltd.). BE 0904864; CH 668069; ES 8707231; GB 2176185; JP 1987048668; US 4652562 . |
【2】
Nógrádi, M.; Berényi, E.; Blaskó, G.; Troquidazole. Drugs Fut 1992, 17, 5, 384. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11660 |
2-Nitroacetaldehyde oximesodium salt
|
|
C2H3N2NaO3 |
详情 |
详情
|
(II) |
11661 |
2-Aminobenzoic acid;Anthranilic acid; o-Aminobenzoic acid |
118-92-3 |
C7H7NO2 |
详情 | 详情
|
(III) |
11662 |
2-[[(E)-2-Nitroethylidene]amino]benzoic acid
|
|
C9H8N2O4 |
详情 |
详情
|
(IV) |
11663 |
3-Nitro-4-quinolinol; 3-Nitro-quinolin-4-ol
|
|
C9H6N2O3 |
详情 |
详情
|
(V) |
11664 |
4-Chloro-3-nitroquinoline
|
|
C9H5ClN2O2 |
详情 |
详情
|
(VI) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(VII) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(VIII) |
11667 |
4-Morpholinecarboximidamide
|
|
C5H11N3O |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of S-methylisothiourea (I) with Boc2O by means of NaHCO3 gives the N-Boc protected isothiourea (II), which is condensed with 1,4-butanediamine (III) in hot THF to yield the guanidine derivative (IV). The acylation of the amino group of (IV) with 3,4-dimethoxycinnamoyl chloride (V) with THF/DMF affords the corresponding amide (VI), which is deprotected with TFA to provide N-(4-guanidinobutyl)-3,4-dimethoxycinnamamide (VII). Finally, the guanidino group of (VII) is alkylated with 3-methyl-2-butenyl bromide (VIII) catalyzed by DMAP in THF to provide the target, caracasanamide.
【1】
Delle Monache, G.; Delle Monache, F.; Botta, B.; Bonnevaux Castillo, S.; Espinal, R.; De Luca, C.; Carmignani, M. (Consiglio Nazionale delle Ricerche); Guanidine derivs. having hypotensive activity, compsn. containing them, and process for obtaining them. EP 0330629; JP 1990003661; US 5059624 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(II) |
22345 |
tert-butyl (E)-[(tert-butoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate
|
|
C12H22N2O4S |
详情 |
详情
|
(III) |
42070 |
1,4-butanediamine; 4-aminobutylamine
|
110-60-1 |
C4H12N2 |
详情 | 详情
|
(IV) |
53109 |
tert-butyl (Z)-[(4-aminobutyl)amino][(tert-butoxycarbonyl)amino]methylidenecarbamate
|
n/a |
C15H30N4O4 |
详情 | 详情
|
(V) |
33601 |
(E)-3-(3,4-dimethoxyphenyl)-2-propenoyl chloride
|
|
C11H11ClO3 |
详情 |
详情
|
(VI) |
53110 |
tert-butyl (Z)-[(tert-butoxycarbonyl)amino][(4-{[(E)-3-(3,4-dimethoxyphenyl)-2-propenoyl]amino}butyl)amino]methylidenecarbamate
|
n/a |
C26H40N4O7 |
详情 | 详情
|
(VII) |
53111 |
(E)-N-(4-{[amino(imino)methyl]amino}butyl)-3-(3,4-dimethoxyphenyl)-2-propenamide
|
n/a |
C16H24N4O3 |
详情 | 详情
|
(VIII) |
12989 |
4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene
|
870-63-3 |
C5H9Br |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
The synthesis of MD-39-AM (V) was carried out as follows:
From 2-chloronicotinic acid (as its acyl chloride) (I) and thiourea in triethylamine (1:1:2), compound (II) was obtained. However, in order to avoid the substitution of 2-Cl by sulfur, 2-methylisothiourea was used. By boiling a solution of (II) in dimethylformamide (DMF) for 15 min, (III) (87%) was obtained. Reaction of (III) with phosphorous oxychloride gave 4-chloro-2-(methylthio)pyrido[2,3-d]pyrimidine (IV) (90%). By reacting (IV) with aniline in ethanol, MD-39-AM was obtained.
【1】
Martinez-Merino, V.; Ochoa, M.C.; Fernandez, F.J.; Artigas, P.; Monge, A.; Bellver, C.; Sanmartin, C.; Fernandez-Alvarez, E.; 2-Arylamino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidines: Synthesis and diuretic activity. Eur J Med Chem 1989, 24, 209.
|
【2】
Martinez-Merino, V.; Monge, A.; Sanmartin, C.; MD-39-AM. Drugs Fut 1992, 17, 2, 107.
|
【3】
Ochoa, M.C.; Fernández, F.J.; Sanmartín, C.; Monge, A.; Martínez-Merino, V.; Bellver, C.; Artigas, P.; Diuretic and hypotensive activities of 4-anilino derivatives of 2-methylthiopyrido[2,3-d]pyrimidines. Arzneim-Forsch Drug Res 1990, 40, 11, 1230-3. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(I) |
15224 |
2-chloronicotinoyl chloride
|
49609-84-9 |
C6H3Cl2NO |
详情 | 详情
|
(II) |
15225 |
2-chloro-3-([[imino(methylsulfanyl)methyl]amino]carbonyl)pyridine
|
|
C8H8ClN3OS |
详情 |
详情
|
(III) |
15226 |
2-(methylsulfanyl)pyrido[2,3-d]pyrimidin-4-ol
|
|
C8H7N3OS |
详情 |
详情
|
(IV) |
15227 |
4-chloropyrido[2,3-d]pyrimidin-2-yl methyl sulfide; 4-chloro-2-(methylsulfanyl)pyrido[2,3-d]pyrimidine
|
|
C8H6ClN3S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XV) 4) The selective deacetylation of 4-O,5-N,7-O,8-O,9-O-pentaacetyl-2,3-didehydro-2-deoxyneuraminic acid (XI) with boron trifluoride ethearate in benzene/methanol gives the 4-deacetyl derivative (XII), which is treated with trifluoromethanesulfonic anhydride in dichloromethane and with sodium azide in DMF to obtain the 4-azido-4-deoxy derivative (XIII). The reduction of (XIII) with H2S in pyridine affords the corresponding 4-amino derivative (XIV), which is finally condensed with S-methylisothiourea in water and saponified through Dowex 50W x 8 in aqueous NH4OH.
【1】
Von Itzstein, L.M.; Wu, W.-Y.; Phan, T.; Danylec, B.; Derivs. and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents. EP 0786458; WO 9116320 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
15985 |
methyl (2R,3S,4S)-3-(acetamido)-4-(acetoxy)-2-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylate
|
|
C20H27NO12 |
详情 |
详情
|
(XII) |
15986 |
methyl (2R,3R,4S)-3-(acetamido)-4-hydroxy-2-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylate
|
|
C18H25NO11 |
详情 |
详情
|
(XIII) |
15979 |
methyl (2R,3R,4S)-3-(acetamido)-4-azido-2-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylate
|
|
C18H24N4O10 |
详情 |
详情
|
(XIV) |
15988 |
methyl (2R,3R,4S)-3-(acetamido)-4-amino-2-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylate
|
|
C18H26N2O10 |
详情 |
详情
|
(XV) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) An improved synthesis of [14C]-peldesine has been reported:
The reaction of S-methyl-[14C]-isothiourea (I) with methyl chloroformate (II) by means of tetrabutylammonium bromide in dichloromethane gives N,N'-bis(methoxycarbonyl)-S-methyl-[14C]-isothiourea (III). This compound is condensed with 3-amino-4-(3-pyridylmethyl)-1H-pyrrole-2-carboxylic acid methyl ester (IV) by means of acetic acid in methanol yielding the labeled guanidine (V). The cyclization of (V) by means of sodium methoxide in methanol affords the carbamate precursor (VI), which is finally deprotected with NaOH in hot water.
【1】
Elliott, A.J.; Kwong, C.D.; Montgomery, J.A.; An improved synthesis of 9-(3-pyridylmethyl)-[2-14C]-9-deazaguanine. J Label Compd Radiopharm 1998, 41, 10, 879.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(I) |
44636 |
[[amino(imino)methyl]sulfanyl]methane
|
|
C2H6N2S |
详情 |
详情
|
(II) |
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(III) |
28696 |
methyl (Z)-[(methoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate
|
|
C6H10N2O4S |
详情 |
详情
|
(III) |
45292 |
methyl (Z)-[(methoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate
|
|
C6H10N2O4S |
详情 |
详情
|
(IV) |
16030 |
methyl 3-amino-4-(3-pyridinylmethyl)-1H-pyrrole-2-carboxylate
|
|
C12H13N3O2 |
详情 |
详情
|
(V) |
28697 |
methyl 3-([bis[(methoxycarbonyl)amino]methylene]amino)-4-(3-pyridinylmethyl)-1H-pyrrole-2-carboxylate
|
|
C17H19N5O6 |
详情 |
详情
|
(V) |
45293 |
methyl 3-([bis[(methoxycarbonyl)amino]methylene]amino)-4-(3-pyridinylmethyl)-1H-pyrrole-2-carboxylate
|
|
C17H19N5O6 |
详情 |
详情
|
(VI) |
28698 |
methyl 4-oxo-7-(3-pyridinylmethyl)-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-ylcarbamate
|
|
C14H13N5O3 |
详情 |
详情
|
(VI) |
45294 |
methyl 4-oxo-7-(3-pyridinylmethyl)-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-ylcarbamate
|
|
C14H13N5O3 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
The reaction of 4-chlorobenzoylhydrazide (I) with S-methyl isothiourea sulfate in aqueous NaOH gave guanidine (II) which, on heating at 220 C, was converted into aminotriazole (III). Subsequent condensation with methyl isothiocyanate in DMF gave thiocarbonyl triazole (IV). Finally, cyclization with diethoxymethyl acetate at 90 C provided the target triazolotriazine.
【1】
Akahoshi, F.; et al.; Synthesis and pharmacological activity of triazolo[1,5-a]triazine derivatives inhibiting eosinophilia. J Med Chem 1998, 41, 16, 2985-2993.
|
【2】
Naito, Y.; et al.; Synthesis and pharmacological activity of triazole derivatives inhibiting eosinophilia. J Med Chem 1996, 39, 15, 3019-3029.
|
【3】
Akahoshi, F.; Okada, T.; Takeda, S.; Naito, Y.; Fukaya, C.; Kuwahara, S.; Kajii, M.; Nishimura, H.; Sugiura, M. (Welfide Corporation); Triazole derivs. and pharmaceutical use thereof. EP 0710654; JP 1995082270; JP 1995097321; JP 1995101942; US 5750545; WO 9503286 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(I) |
18216 |
4-chlorobenzohydrazide; p-chloro-benzoylhydrazine
|
536-40-3 |
C7H7ClN2O |
详情 | 详情
|
(II) |
18217 |
2-(4-chlorobenzoyl)-1-hydrazinecarboximidamide
|
|
C8H9ClN4O |
详情 |
详情
|
(III) |
18218 |
5-(4-chlorophenyl)-1H-1,2,4-triazol-3-ylamine; 5-(4-chlorophenyl)-1H-1,2,4-triazol-3-amine
|
|
C8H7ClN4 |
详情 |
详情
|
(IV) |
18219 |
5-amino-3-(4-chlorophenyl)-N-methyl-1H-1,2,4-triazole-1-carbothioamide
|
|
C10H10ClN5S |
详情 |
详情
|
(V) |
17661 |
Diethoxymethyl acetate
|
14036-06-7 |
C7H14O4 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The condensation of 4-fluorobenzaldehyde (I) with 4-methyl-3-oxopentanoic acid ethyl ester (II) by means of piperidine/AcOH in refluxing benzene gives the corresponding benzylidene derivative (III), which is cyclized with S-methylisothiourea (IV) and oxidized with DDQ, affording the pyrimidine derivative (V). The oxidation of (V) with m-chloroperbenzoic acid (m-CPBA) gives the expected methanesulfonyl derivative (VI), which is treated first with methylamine and then with methanesulfonyl chloride to provide the N-methylmethanesulfonamide (VII). The reduction of the ester group of (VII) with DIBAL in toluene, followed by selective oxidation of the resulting alcohol with TPAP, affords the aldehyde (VIII), which is submitted to a Wittig condensation with the phosphorane (IX) in acetonitrile to give the protected heptenoate (X). The deprotection of (X) with FH and the controlled reduction of the resulting keto alcohol with Et2BOMe and NaBH4 affords the chiral dihydroxyheptenoate (XI), which is hydrolyzed with NaOH in ethanol, yielding the corresponding sodium salt (XII). Finally, this compound is treated with calcium chloride.
【1】
Watanabe, M.; et al.; Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem 1997, 5, 2, 437.
|
【2】
Castañer, J.; Graul, A.; ZD-4522. Drugs Fut 1999, 24, 5, 511.
|
【3】
Hirai, K.; Ishiba, T.; Koike, H.; Watanabe, M. (Shionogi & Co. Ltd.); Pyrimidine derivs. as HMG-CoA reductase inhibitors. EP 0521471; JP 1993178841; US 5260440 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
19408 |
ethyl 4-methyl-3-oxopentanoate
|
7152-15-0 |
C8H14O3 |
详情 | 详情
|
(III) |
15877 |
ethyl (Z)-3-(4-fluorophenyl)-2-isobutyryl-2-propenoate
|
|
C15H17FO3 |
详情 |
详情
|
(IV) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(V) |
23879 |
ethyl 4-(4-fluorophenyl)-6-isopropyl-2-(methylsulfanyl)-5-pyrimidinecarboxylate
|
|
C17H19FN2O2S |
详情 |
详情
|
(VI) |
23880 |
ethyl 4-(4-fluorophenyl)-6-isopropyl-2-(methylsulfonyl)-5-pyrimidinecarboxylate
|
|
C17H19FN2O4S |
详情 |
详情
|
(VII) |
23881 |
ethyl 4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinecarboxylate
|
|
C18H22FN3O4S |
详情 |
详情
|
(VIII) |
23882 |
N-[4-(4-fluorophenyl)-5-formyl-6-isopropyl-2-pyrimidinyl]-N-methylmethanesulfonamide
|
147118-37-4 |
C16H18FN3O3S |
详情 | 详情
|
(IX) |
23884 |
methyl (3R)-3-[[tert-butyl(dimethyl)silyl]oxy]-5-oxo-6-(triphenylphosphoranylidene)hexanoate
|
147118-35-2 |
C31H39O4PSi |
详情 | 详情
|
(X) |
23883 |
methyl (3R,6E)-3-[[tert-butyl(dimethyl)silyl]oxy]-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-oxo-6-heptenoate
|
147118-38-5 |
C29H42FN3O6SSi |
详情 | 详情
|
(XI) |
23885 |
methyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoate
|
147118-40-9 |
C23H30FN3O6S |
详情 | 详情
|
(XII) |
23887 |
sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoate
|
147098-18-8 |
C22H27FN3NaO6S |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) N-Boc-ethylenediamine (I) was treated with S-methylisothiourea (II) yielding guanidine (III). The Boc group of (III) was then cleaved by treatment with HCl.
【1】
Cozzi, P.; Beria, I.; Biasoli, G.; Caldarelli, M.; Capolongo, L.; Franzetti, C. (Pharmacia & Upjohn AB); Acryloyl substd. distamycin derivs., process for preparing them, and their use as antitumor and antiviral agents. WO 9804524 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(II) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(III) |
41436 |
tert-butyl 2-[[amino(imino)methyl]amino]ethylcarbamate
|
|
C8H18N4O2 |
详情 |
详情
|
(IV) |
41437 |
N-(2-aminoethyl)guanidine
|
|
C3H10N4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XII) Protection of 3-amino-5-methylphenol (I) with phthalic anhydride (II) provided the phthalimido derivative (III), which was alkylated with ethyl 4-bromobutyrate (IV) in the presence of K2CO3 to give the corresponding ether (V). Hydrazinolysis of the phthalimido group of (V) afforded the primary amine (VI), which was condensed with benzenesulfonyl chloride (VII), yielding sulfonamide (VIII). Saponification of the ethyl ester of (VIII) gave carboxylic acid (IX). After conversion to the mixed anhydride with isobutyl chloroformate and N-methylmorpholine, treatment with methanolic ammonia furnished amide (X). This was reduced to amine (XI) using LiAlH4 in THF. Finally, reaction of (XI) with S-methylisothiouronium sulfate (XII) in refluxing EtOH provided the target guanidine.
【1】
Weber, I.R.; Neidlein, R.; von der Saal, W.; Grams, F.; Leinert, H.; Strein, K.; Engh, R.A.; Kucznierz, R.; Diarylsulfonamides as selective, non-peptidic thrombin inhibitors. Bioorg Med Chem Lett 1998, 8, 13, 1613.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II)) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(I) |
31435 |
3-amino-5-methylphenol
|
|
C7H9NO |
详情 |
详情
|
(III) |
31436 |
2-(3-hydroxy-5-methylphenyl)-1H-isoindole-1,3(2H)-dione
|
|
C15H11NO3 |
详情 |
详情
|
(IV) |
11263 |
ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate
|
2969-81-5 |
C6H11BrO2 |
详情 | 详情
|
(V) |
31437 |
ethyl 4-[3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-methylphenoxy]butanoate
|
|
C21H21NO5 |
详情 |
详情
|
(VI) |
31438 |
ethyl 4-(3-amino-5-methylphenoxy)butanoate
|
|
C13H19NO3 |
详情 |
详情
|
(VII) |
14713 |
benzenesulfonyl chloride
|
98-09-9 |
C6H5ClO2S |
详情 | 详情
|
(VIII) |
31439 |
ethyl 4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butanoate
|
|
C19H23NO5S |
详情 |
详情
|
(IX) |
31441 |
4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butyric acid
|
|
C17H19NO5S |
详情 |
详情
|
(X) |
31440 |
4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butanamide
|
|
C17H20N2O4S |
详情 |
详情
|
(XI) |
31442 |
N-[3-(4-aminobutoxy)-5-methylphenyl]benzenesulfonamide
|
|
C17H22N2O3S |
详情 |
详情
|
(XII) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(I) Condensation of S-methylisothiourea (I) and cyano acetate derivative (II) by means of NaOMe in MeOH affords pyrimidine derivative (III), whose hydroxy group is converted into chloro by means of refluxing POCl3, yielding derivative (IV). Alkylation of (IV) with cyclopentylamine (V) and Et3N in CH2Cl2 provides derivative (VI), whose nitrile group is then reduced by means of LiAlH4 in THF to afford aminomethyl compound (VII). Treatment of (VII) with 1,1-carbonyldiimidazole (CDI) in refluxing THF gives pyrimidopyrimidinone (VIII), whose methylsulfanyl group is oxidized with 3-phenyl-2-(phenylsulfonyl)oxaziridine (IX) in CHCl3 to afford methyl sulfoxide derivative (X). Displacement of the methyl sulfoxide group of (X) with substituted aniline (XI) in TFA/acetonitrile yields 3,4-dihydropyrimidopyrimidinone (XII), which is finally oxidized by means of KOtBu in THF or DMSO.
【1】
Kramer, J.B.; et al.; Synthesis and biological activity of a novel series of pyrimidopyrimidinones as inhibitors of cyclin-dependent kinases. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 40.
|
【2】
Dobrusin, E.M.; Showalter, H.D.H.; Schroeder, M.C.; Toogood, P.; Kramer, J.B.; Trumpp-Kallmeyer, S.A.; Hamby, J.M. (Pfizer Inc.); Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation. WO 9961444 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIa) |
43041 |
ethyl (Z)-2-cyano-3-ethoxy-2-propenoate
|
94-05-3 |
C8H11NO3 |
详情 | 详情
|
(IIb) |
43563 |
ethyl (E)-2-cyano-3-ethoxy-2-propenoate;(E)-ethyl 2-cyano-3-ethoxyacrylate |
94-05-3 |
C8H11NO3 |
详情 | 详情
|
(I) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(III) |
43555 |
4-hydroxy-2-(methylsulfanyl)-5-pyrimidinecarbonitrile
|
|
C6H5N3OS |
详情 |
详情
|
(IV) |
43556 |
4-chloro-2-(methylsulfanyl)-5-pyrimidinecarbonitrile
|
|
C6H4ClN3S |
详情 |
详情
|
(V) |
28850 |
cyclopentanamine
|
1003-03-8 |
C5H11N |
详情 | 详情
|
(VI) |
43557 |
4-(cyclopentylamino)-2-(methylsulfanyl)-5-pyrimidinecarbonitrile
|
|
C11H14N4S |
详情 |
详情
|
(VII) |
43558 |
N-[5-(aminomethyl)-2-(methylsulfanyl)-4-pyrimidinyl]-N-cyclopentylamine; 5-(aminomethyl)-N-cyclopentyl-2-(methylsulfanyl)-4-pyrimidinamine
|
|
C11H18N4S |
详情 |
详情
|
(VIII) |
43559 |
1-cyclopentyl-7-(methylsulfanyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
|
|
C12H16N4OS |
详情 |
详情
|
(IX) |
31834 |
3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine;2-(Phenylsulfonyl)-3-phenyloxaziridine;2-Benzenesulfonyl-3-phenyloxaziridine;3-Phenyl-2-phenylsulfonyloxaziridine;3-Phenyl-N-phenylsulfonyloxaziridine;N-(Phenylsulfonyl)phenyloxaziridine;N-Benzenesulfonyl-3-phenyloxaziridine |
63160-13-4 |
C13H11NO3S |
详情 | 详情
|
(X) |
43560 |
1-cyclopentyl-7-(methylsulfinyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
|
|
C12H16N4O2S |
详情 |
详情
|
(XI) |
43561 |
1-(4-aminophenyl)-4-piperidinol
|
|
C11H16N2O |
详情 |
详情
|
(XII) |
43562 |
1-cyclopentyl-7-[4-(4-hydroxy-1-piperidinyl)anilino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
|
|
C22H28N6O2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The condensation between 3-methoxybenzaldehyde (I), S-methylisothiourea (II) and ethyl cyanoacetate (III) in the presence of K2CO3 in hot EtOH leads to pyrimidine (IV). Subsequent chlorination of (IV) by means of POCl3 and dimethylaniline furnishes the 6-chloropyrimidine (V). Reaction of (V) with ethyl mercaptoacetate (VI) and potassium tert-butoxide gives rise to the thienopyrimidine (VII). The ethyl ester group of (VII) is then hydrolyzed to the carboxylic acid (VIII) employing LiOH. Finally, coupling of acid (VIII) with tert-butylamine by means of TBTU produces the target N-tert-butyl amide
【1】
Adang, A.E.P.; Gerritsma, G.G.; Van Straten, N.C.R. (Akzo Nobel N.V.); Bicyclic heteroaromatic cpds. useful as LH agonists. EP 1171443; JP 2002541259; US 6569863; WO 0061586 .
|
【2】
Timmers, C.M.; Karstens, W.F.J. (Akzo Nobel N.V.); Bicyclic heteroaromatic cpds.. WO 0224703 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20589 |
3-methoxybenzaldehyde; m-Anisaldehyde
|
591-31-1 |
C8H8O2 |
详情 | 详情
|
(II) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
(III) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(IV) |
60410 |
4-hydroxy-6-(3-methoxyphenyl)-2-(methylsulfanyl)-5-pyrimidinecarbonitrile
|
|
C13H11N3O2S |
详情 |
详情
|
(V) |
60411 |
4-chloro-6-(3-methoxyphenyl)-2-(methylsulfanyl)-5-pyrimidinecarbonitrile
|
|
C13H10ClN3OS |
详情 |
详情
|
(VI) |
23995 |
ethyl 2-sulfanylacetate
|
2713-34-0 |
C4H8O2S |
详情 | 详情
|
(VII) |
60412 |
ethyl 5-amino-4-(3-methoxyphenyl)-2-(methylsulfanyl)thieno[2,3-d]pyrimidine-6-carboxylate
|
|
C17H17N3O3S2 |
详情 |
详情
|
(VIII) |
60413 |
5-amino-4-(3-methoxyphenyl)-2-(methylsulfanyl)thieno[2,3-d]pyrimidine-6-carboxylic acid
|
|
C15H13N3O3S2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(VI) The Friedel Krafts reaction of fluorobenzene (I) and 3-nitro-4-chlorobenzoyl chloride (II) by means of AlCl3 gives 3-nitro-4-chloro-4’-fluorobenzophenone (III), which by reaction with NH3 in ethylenglycol at 130 C yields 3-nitro-4-amino-4’-fluorobenzophenone (IV). The reduction of (IV) with H2 over Pd/C in methanol affords 3,4-diamino-4’-fluorobenzophenone (V), which is finally cyclized with S-methylthiourea (VI) and methyl chloroformate by means of NaOH in water
【1】
Tan, K.; Duquette, M.; Liu, J.H.; Dong, Y.; Zhang, R.; Joachimiak, A.; Lawler, J.; Wang, J.H.; Crystal structure of the TSP-1 type 1 repeats: A novel layered fold and its biological implication. Arzneim-Forsch Drug Res 1978, 28, 4, 586.
|
【2】
Van Gelder, J.L.H.; et al. (Janssen Pharmaceutica NV); BE 752089; DE 2029637; FR 2052988; GB 1307306; US 3657267; ZA 7004191 .
|
【3】
Castaner, J.; Bogan, J.A.; Flubendazole.. Drugs Fut 1978, 3, 10, 739.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17466 |
Fluorobenzene
|
462-06-6 |
C6H5F |
详情 | 详情
|
(II) |
14486 |
4-Chloro-3-nitrobenzoylchloride; 4-chloro-3-nitrobenzoyl chloride
|
38818-50-7 |
C7H3Cl2NO3 |
详情 | 详情
|
(III) |
60714 |
(4-chloro-3-nitrophenyl)(4-fluorophenyl)methanone
|
|
C13H7ClFNO3 |
详情 |
详情
|
(IV) |
60715 |
(4-amino-3-nitrophenyl)(4-fluorophenyl)methanone
|
|
C13H9FN2O3 |
详情 |
详情
|
(V) |
60716 |
(3,4-diaminophenyl)(4-fluorophenyl)methanone
|
|
C13H11FN2O |
详情 |
详情
|
(VI) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(V) The condensation of 2-(chloromethyl)-1,4-dioxaspiro[4,5]decane (I) with the sodium salt of phthalimide (II) in hot DMF affords the N-substituted phthalimide (III). Subsequent phthaloyl group hydrazinolysis gives the primary amine (IV). Finally, condensation of amine (IV) with S-methyl pseudothiourea sulfate (V) leads to the title guanidine derivative
【1】
Aaron, J.E. Jr.; Hardie, W.R.; Process for the preparation of 1,3-dioxolan-4-yl-alcoyl-guanidines and its intermediates. FR 1522153 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62349 |
2-(chloromethyl)-1,4-dioxaspiro[4.5]decane
|
|
C9H15ClO2 |
详情 |
详情
|
(II) |
12376 |
Phthalimide; 1H-Isoindole-1,3(2H)-dione; Isoindole-1,3-dione;Phthalic dicarboximide;Phenylimide;Isoindole-1,3-dione |
85-41-6 |
C8H5NO2 |
详情 | 详情
|
(III) |
62350 |
2-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)-1H-isoindole-1,3(2H)-dione
|
|
C17H19NO4 |
详情 |
详情
|
(IV) |
62351 |
1,4-dioxaspiro[4.5]dec-2-ylmethanamine; 1,4-dioxaspiro[4.5]dec-2-ylmethylamine
|
|
C9H17NO2 |
详情 |
详情
|
(V) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(VIII) The reaction of 4-chloro-2-amino-1-nitrobenzene (I) with sodium phenylmercaptide (A) in DMF gives 2-amino-4-phenylthio-1-nitrobenzene (II), which is treated with acetic anhydride to yield 2-acetamido-4-phenylthio-1-nitrobenzene (III). This product is oxidized with peracetic acid in methanol giving 2-amino-4-phenylsulfinyl-1-nitrobenzene (V). Then the nitro group is reduced with H2 over Pd/C in methanol yielding 1,2-diamino-4-phenylsulfinylbenzene (VI). This product is finally condensed with N,N'-bis(methoxycarbonyl)-S-methylisothiourea (VII) in ethanol - water - acetic acid. The isothiourea (VII) is obtained by reaction of S-methylisothiouronium sulfate (VIII) with methyl chloroformate (B) by means of KOH in water
【1】
Beard, C.C.; et al. (Syntex, Inc.); DE 2363351 .
|
【2】
Castaner, J.; Bogan, J.A.; Oxfendazole. Drugs Fut 1976, 1, 9, 438.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(A) |
60753 |
sodium benzenethiolate
|
|
C6H5NaS |
详情 |
详情
|
(I) |
15709 |
5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline
|
1635-61-6 |
C6H5ClN2O2 |
详情 | 详情
|
(II) |
60754 |
2-nitro-5-(phenylsulfanyl)aniline; 2-nitro-5-(phenylsulfanyl)phenylamine
|
|
C12H10N2O2S |
详情 |
详情
|
(III) |
60755 |
N-[2-nitro-5-(phenylsulfanyl)phenyl]acetamide
|
|
C14H12N2O3S |
详情 |
详情
|
(IV) |
60756 |
N-[2-nitro-5-(phenylsulfinyl)phenyl]acetamide
|
|
C14H12N2O4S |
详情 |
详情
|
(V) |
60757 |
2-nitro-5-(phenylsulfinyl)aniline; 2-nitro-5-(phenylsulfinyl)phenylamine
|
|
C12H10N2O3S |
详情 |
详情
|
(VI) |
60758 |
4-(phenylsulfinyl)-1,2-benzenediamine; 2-amino-4-(phenylsulfinyl)phenylamine
|
|
C12H12N2OS |
详情 |
详情
|
(VII) |
28696 |
methyl (Z)-[(methoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate
|
|
C6H10N2O4S |
详情 |
详情
|
(VIII) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|